GLP-1 medications have transformed the treatment of diabetes and obesity, but scientists are still uncovering exactly how they work. In this Science in Seconds segment, pharmacology and neuroscience researcher Samantha Fortin explains how her lab is focusing on how these drugs affect the brain and how they can be improved for the future.